Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

WhiteSwell has reported encouraging results from its DELTA-HF trial, which evaluated the minimally invasive catheter-based ...